Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × elemene × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Carboplatin 12 Pemetrexed 11 pembrolizumab 10 Paclitaxel 6 Cisplatin 6 Erlotinib Hydrochloride 5 Docetaxel 5 Nivolumab 4 Gefitinib 4 spartalizumab 3 osimertinib 3 Gemcitabine 3 EC145 3 Crizotinib 3 Afatinib 3 technetium 99m etarfolatide 2 pralsetinib 2 cemiplimab 2 brigatinib 2 alpha-2'-deoxythioguanosine 2 Vinorelbine 2 Radiotherapy 2 MORAb-202 2 Blood Specimen Collection 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 vosaroxin 1 vistusertib 1 vandetanib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡